Literature DB >> 21856186

Tight regulation of memory CD8(+) T cells limits their effectiveness during sustained high viral load.

Erin E West1, Ben Youngblood, Wendy G Tan, Hyun-Tak Jin, Koichi Araki, Gabriela Alexe, Bogumila T Konieczny, Silvia Calpe, Gordon J Freeman, Cox Terhorst, W Nicholas Haining, Rafi Ahmed.   

Abstract

To design successful vaccines for chronic diseases, an understanding of memory CD8(+) T cell responses to persistent antigen restimulation is critical. However, most studies comparing memory and naive cell responses have been performed only in rapidly cleared acute infections. Herein, by comparing the responses of memory and naive CD8(+) T cells to acute and chronic lymphocytic choriomeningitis virus infection, we show that memory cells dominated over naive cells and were protective when present in sufficient numbers to quickly reduce infection. In contrast, when infection was not rapidly reduced, because of high antigen load or persistence, memory cells were quickly lost, unlike naive cells. This loss of memory cells was due to a block in sustaining cell proliferation, selective regulation by the inhibitory receptor 2B4, and increased reliance on CD4(+) T cell help. Thus, emphasizing the importance of designing vaccines that elicit effective CD4(+) T cell help and rapidly control infection.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21856186      PMCID: PMC3241982          DOI: 10.1016/j.immuni.2011.05.017

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  56 in total

1.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

2.  Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy.

Authors:  Christian S Hinrichs; Zachary A Borman; Luca Gattinoni; Zhiya Yu; William R Burns; Jianping Huang; Christopher A Klebanoff; Laura A Johnson; Sid P Kerkar; Shicheng Yang; Pawel Muranski; Douglas C Palmer; Christopher D Scott; Richard A Morgan; Paul F Robbins; Steven A Rosenberg; Nicholas P Restifo
Journal:  Blood       Date:  2010-10-22       Impact factor: 22.113

3.  Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.

Authors:  Hyun-Tak Jin; Ana C Anderson; Wendy G Tan; Erin E West; Sang-Jun Ha; Koichi Araki; Gordon J Freeman; Vijay K Kuchroo; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

Review 4.  T cell exhaustion.

Authors:  E John Wherry
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

5.  Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis.

Authors:  Stephen N Waggoner; Ruth T Taniguchi; Porunelloor A Mathew; Vinay Kumar; Raymond M Welsh
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

6.  Cutting edge: The adapters EAT-2A and -2B are positive regulators of CD244- and CD84-dependent NK cell functions in the C57BL/6 mouse.

Authors:  Ninghai Wang; Silvia Calpe; Jill Westcott; Wilson Castro; Chunyan Ma; Pablo Engel; John D Schatzle; Cox Terhorst
Journal:  J Immunol       Date:  2010-10-20       Impact factor: 5.422

7.  Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation.

Authors:  Bertram Bengsch; Bianca Seigel; Marianne Ruhl; Jörg Timm; Martin Kuntz; Hubert E Blum; Hanspeter Pircher; Robert Thimme
Journal:  PLoS Pathog       Date:  2010-06-10       Impact factor: 6.823

8.  The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function.

Authors:  Bijan Raziorrouh; Winfried Schraut; Tilman Gerlach; Daniela Nowack; Norbert H Grüner; Axel Ulsenheimer; Reinhart Zachoval; Martin Wächtler; Michael Spannagl; Jürgen Haas; Helmut M Diepolder; Maria-Christina Jung
Journal:  Hepatology       Date:  2010-11-09       Impact factor: 17.425

9.  Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine.

Authors:  Scott G Hansen; Julia C Ford; Matthew S Lewis; Abigail B Ventura; Colette M Hughes; Lia Coyne-Johnson; Nathan Whizin; Kelli Oswald; Rebecca Shoemaker; Tonya Swanson; Alfred W Legasse; Maria J Chiuchiolo; Christopher L Parks; Michael K Axthelm; Jay A Nelson; Michael A Jarvis; Michael Piatak; Jeffrey D Lifson; Louis J Picker
Journal:  Nature       Date:  2011-05-11       Impact factor: 49.962

10.  Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells.

Authors:  N Sevilla; S Kunz; A Holz; H Lewicki; D Homann; H Yamada; K P Campbell; J C de La Torre; M B Oldstone
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

View more
  93 in total

Review 1.  Vaccination: the present and the future.

Authors:  Saheli Sadanand
Journal:  Yale J Biol Med       Date:  2011-12

Review 2.  New Strategies in Engineering T-cell Receptor Gene-Modified T cells to More Effectively Target Malignancies.

Authors:  Thomas M Schmitt; Ingunn M Stromnes; Aude G Chapuis; Philip D Greenberg
Journal:  Clin Cancer Res       Date:  2015-10-13       Impact factor: 12.531

3.  Selective Loss of Signaling Lymphocytic Activation Molecule Family Member 4-Positive CD8+ T Cells Contributes to the Decreased Cytotoxic Cell Activity in Systemic Lupus Erythematosus.

Authors:  Katalin Kis-Toth; Denis Comte; Maria P Karampetsou; Vasileios C Kyttaris; Lakshmi Kannan; Cox Terhorst; George C Tsokos
Journal:  Arthritis Rheumatol       Date:  2016-01       Impact factor: 10.995

4.  Acute Viral Respiratory Infection Rapidly Induces a CD8+ T Cell Exhaustion-like Phenotype.

Authors:  John J Erickson; Pengcheng Lu; Sherry Wen; Andrew K Hastings; Pavlo Gilchuk; Sebastian Joyce; Yu Shyr; John V Williams
Journal:  J Immunol       Date:  2015-09-23       Impact factor: 5.422

Review 5.  Re-adapting T cells for cancer therapy: from mouse models to clinical trials.

Authors:  Ingunn M Stromnes; Thomas M Schmitt; Aude G Chapuis; Sunil R Hingorani; Philip D Greenberg
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 6.  T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases.

Authors:  Eoin F McKinney; Kenneth Gc Smith
Journal:  Immunol Cell Biol       Date:  2016-11       Impact factor: 5.126

7.  Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection.

Authors:  Jeffrey E Teigler; Gennadiy Zelinskyy; Michael A Eller; Diane L Bolton; Mary Marovich; Alexander D Gordon; Aljawharah Alrubayyi; Galit Alter; Merlin L Robb; Jeffrey N Martin; Steven G Deeks; Nelson L Michael; Ulf Dittmer; Hendrik Streeck
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

Review 8.  Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease.

Authors:  John Attanasio; E John Wherry
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

9.  Qualitative and quantitative analysis of adenovirus type 5 vector-induced memory CD8 T cells: not as bad as their reputation.

Authors:  Maria Abildgaard Steffensen; Peter Johannes Holst; Sanne Skovvang Steengaard; Benjamin Anderschou Holbech Jensen; Christina Bartholdy; Anette Stryhn; Jan Pravsgaard Christensen; Allan Randrup Thomsen
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

10.  TCR independent suppression of CD8(+) T cell cytokine production mediated by IFNγ in vivo.

Authors:  Martin P Hosking; Claudia T Flynn; J Lindsay Whitton
Journal:  Virology       Date:  2016-08-24       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.